Incyte (INCY) Interest Coverage Ratio (2010 - 2026)

Incyte (INCY) posted Interest Coverage Ratio of 47.05 for Q1 2026, down 91.85% on a QoQ basis from 577.08 in Q4 2025, and up 33.01% year-over-year from 35.37 in Q1 2025.

Incyte (INCY) Interest Coverage Ratio (2010 - 2026) Analysis & Trends

Incyte's Interest Coverage Ratio history runs 17 years deep, the most recent figure standing at 47.05 for Q1 2026.

  • Quarterly Interest Coverage Ratio rose 33.01% year-over-year to 47.05 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 87.16 (up 33.75% YoY) and the FY2025 annual result came in at 67.63, up 235699.99% from the prior year.
  • Interest Coverage Ratio was 47.05 for Q1 2026 at Incyte, down from 577.08 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 577.08 in Q4 2025 and bottomed at 91.95 in Q2 2024.
  • A 5-year average of 56.81 and a median of 28.09 in 2024 frame the typical range for Interest Coverage Ratio.
  • Annual changes were most pronounced in 2024 — Interest Coverage Ratio tumbled 304.27% — and 2025, when it surged 2687.64%.
  • Incyte's Interest Coverage Ratio stood at 5.82 in 2022, then jumped by 287.44% to 10.92 in 2023, then tumbled by 304.27% to 22.3 in 2024, then jumped by 2687.64% to 577.08 in 2025, then sank by 91.85% to 47.05 in 2026.
  • Business Quant data shows INCY's Interest Coverage Ratio at 47.05 in Q1 2026, 577.08 in Q4 2025, and 76.47 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 658.42
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 7.60
4 NuCana 279.75 Bn 279.75 Bn - -0.22
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.71
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.72
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -0.38
10 Incyte 23.33 Bn 19.32 Bn 1.17 Bn 47.05

Historic Data

Download Data
DateValue
Mar 31, 2026 47.05
Dec 31, 2025 577.08
Sep 30, 2025 76.47
Jun 30, 2025 93.04
Mar 31, 2025 35.37
Dec 31, 2024 -22.30
Sep 30, 2024 28.09
Jun 30, 2024 -91.95
Mar 31, 2024 17.02
Dec 31, 2023 10.92
Sep 30, 2023 42.94
Jun 30, 2023 48.45
Mar 31, 2023 4.42
Dec 31, 2022 -5.82
Sep 30, 2022 27.13
Jun 30, 2022 54.13
Mar 31, 2022 23.78
Dec 31, 2021 28.39
Sep 30, 2021 3.64
Jun 30, 2021 2.18